Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture

Journal of Bone and Joint Surgery

Volumn 83, Issue SUPPL. 1, 2001, Pages

  Dorai, H ^a   Sampath, T K ^a  

^a CURIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; COMPLEMENTARY DNA; HELIX LOOP HELIX PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; OSTEOGENIC PROTEIN 1; RECOMBINANT INTERLEUKIN 6; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; AORTA; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 17644446340     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200100001-00010     Document Type: Conference Paper

References (46)

1. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis
2. Role of subchondral vascular system in endochondral ossification: Endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro
3. The pathogenesis of atherosclerosis - An update
4. The pathogenesis of atherosclerosis: A perspective for the 1990s
5. Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells
6. Platelet-derived growth factor: Mechanism of action and possible in vivo function
7. The heparin-binding (fibroblast) growth factor family of proteins
8. Localization of PDGF-BB protein in macrophages in all phases of atherogenesis
9. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells
10. Progesterone inhibits arterial smooth muscle cell proliferation
11. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
12. Bone: Formation by autoinduction
13. Dissociative extraction and reconstitution of extra-cellular matrix components involved in local bone differentiation
14. Bone morphogenetic proteins in development
15. Anti-ischemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1)
16. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke
17. Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke
18. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat
19. Effect of osteogenic protein-1 on the course of norepinephrine induced acute renal failure
20. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro
21. Induction of Smad6 mRNA by bone morphogenetic protein
22. Vascular smooth muscle cells express multiple type I receptors for TGF-beta, activin, and bone morphogenic proteins
23. Osteogenic protein-1 (OP-1/BMP-7) modulates smooth muscle growth and maintains the expression of cell phenotype and protects against cell injury mediated by nephrotoxic and inflammatory agents in vitro
24. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro
25. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
26. Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGF beta receptor family
27. Prevention of graft coronary arteriosclerosis by antidense cdk-2 kinase oligonucleotides
28. Inhibition of smooth muscle cell migration by p21 cyclin-dependent kinase inhibitor (Cip1)
29. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
30. Smad6 inhibits signaling by the TGF-beta superfamily
31. Identification of Smad7, a TGF-beta inducible antagonist of TGF-beta signalling
32. Tissue necrosis factor (TNF)
33. Cytokines as modulators of cell proliferation in fibrotic diseases
34. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA
35. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
36. Anti-sense c-myb oligonucleotide inhibit intimal arterial smooth muscle accumulation in vivo
37. Transfer and expression of interferon gamma gene in human endothelial cells inhibits vascular smooth muscle cell growth in vitro
38. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1
39. Role of morphogenic proteins in skeletal tissue engineering and regeneration
40. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cell
41. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction
42. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2
43. The transforming growth factor-βs
44. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures
45. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members
46. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium